Omada tackles obesity drugs, boston scientific nixes deal, and microsoft health exec on gpt

Omada tackles obesity drugs, boston scientific nixes deal, and microsoft health exec on gpt

Play all audios:

Loading...

_You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and


Thursday. _ OMADA HEALTH announced it will launch a new service to help employers respond to the soaring demand for expensive GLP-1 weight loss treatments like Wegovy. When employees of


participating companies seek to have their treatments covered by health plans, they’ll be asked to join Omada’s program that encourages lifestyle changes that might help people keep weight


off. Omada, which offers a host of virtual chronic disease management programs that focus on behavior change, won’t actually write or fill prescriptions for the drugs, a service that CEO 


SEAN DUFFY told STAT has been commoditized to the point that people don’t need more options. STAT+ Exclusive Story Already have an account? Log in THIS ARTICLE IS EXCLUSIVE TO STAT+


SUBSCRIBERS UNLOCK THIS ARTICLE — AND GET ADDITIONAL ANALYSIS OF THE TECHNOLOGIES DISRUPTING HEALTH CARE — BY SUBSCRIBING TO STAT+. Already have an account? Log in Individual plans Group


plans View All Plans To read the rest of this story subscribe to STAT+. Subscribe